Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests

BACKGROUND: Emerging blood-based multi-cancer early detection (MCED) tests can detect a variety of cancer types across stages with a range of sensitivity, specificity, and ability to predict the origin of the cancer signal. However, little is known about the general US population’s preferences for M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhorn, Heather, Ross, Melissa M., Kansal, Anuraag R., Fung, Eric T., Seiden, Michael V., Krucien, Nicolas, Chung, Karen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813037/
https://www.ncbi.nlm.nih.gov/pubmed/35844011
http://dx.doi.org/10.1007/s40271-022-00589-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813037/
https://www.ncbi.nlm.nih.gov/pubmed/35844011
http://dx.doi.org/10.1007/s40271-022-00589-5

Ejemplares similares